Molecular therapy for aging-associated diseases and Lifespan extension: Prostaglandin D2 (PGD2), the principal cyclooxygenase (COX2) metabolite of arachidonic acid, increases NMN/NAD levels, decreases interaction of DBC1 with PARP1, increases PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer and aging via down-regulation of its target gene, 27/November/2018, 6.29 am
Molecular therapy for aging-associated diseases and Lifespan extension: Prostaglandin D2 (PGD2), the principal cyclooxygenase (COX2) metabolite of arachidonic acid, increases NMN/NAD levels, decreases interaction of DBC1 with PARP1, increases PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer and aging via down-regulation of its target gene, 27/November/2018, 6.29 am
Spread the love
Spread the love
Let's have a chat!
Sign-up for our newsletter to learn more about upcoming Genomediscovery Forums!